INTECH Investment Management’s Avidity Biosciences RNAM Stock Holding History

INTECH Investment Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-44,454	Closed	-$3.21M	–	2316
2025 Q4	$3.21M	Sell	44,454 -8,499	-16%	-$549K	0.03%	521
2025 Q3	$2.31M	Sell	52,953 -2,986	-5%	-$121K	0.02%	696
2025 Q2	$1.59M	Sell	55,939 -5,736	-9%	-$171K	0.01%	915
2025 Q1	$1.82M	Buy	61,675 +874	+1%	+$27.2K	0.02%	812
2024 Q4	$1.77M	Buy	60,801 +23,765	+64%	+$993K	0.02%	786
2024 Q3	$1.7M	Buy	+37,036	New	+$1.61M	0.02%	549

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

INTECH Investment Management's RNAM Position: Q1 2026 in Review

INTECH Investment Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 44,454 shares — an estimated $3.21M sold.

INTECH Investment Management first reported a position in RNAM in Q3 2024 and held it in 6 quarters. The position peaked at $3.21M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

INTECH Investment Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
INTECH Investment Management sold 44,454 Avidity Biosciences shares in Q1 2026, an estimated $3.21M.
INTECH Investment Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 6 quarters.
INTECH Investment Management's Avidity Biosciences position peaked at $3.21M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.